Why are cancer outcomes poorer in some population groups in countries with universal access to healthcare? Why does access to optimal cancer care vary between different cancer patients? What are the mechanisms leading to such disparities? These are the type of questions our research aims to answer.
- Q&A: Dr Serena PernerWe’re delighted to be joined by Dr Serena Perner from the Institute of Collective Health at the National University of Lanus for the next three months.
- World Cancer Day 2023: Close the Care GapEvery year, 4 February marks World Cancer Day – a global initiative led by the Union for International Cancer Control (UICC). The day aims to raise worldwide awareness of cancer, improving education and catalysing personal, collective and government action. Since […]
- New research shows increased cancer mortality in people with type 2 diabetesNew research by Dr Suping Ling, funded by Hope Against Cancer and published in Diabetologia, shows that cancer mortality in people with type 2 diabetes is substantially higher than the general population – 18% for all cancers combined, 9% for […]
- Science Museum Lates: Could your data save a life?On 25 May 2022, staff and doctoral students from the London School of Hygiene & Tropical Medicine, connected by cancer research, participated in Science Museum Lates – an after-hours opportunity for adults interested in science to engage with leading researchers […]
- Do presenting symptoms, use of pre-diagnostic endoscopy and risk of emergency cancer diagnosis vary by comorbidity burden and type in patients with colorectal cancer?What the study found Most people diagnosed with cancer have pre-existing chronic conditions (also known as comorbidities), which might delay the diagnosis of cancer. To better understand which patient groups are at higher risk of delays and where along the […]
- Differences in colon cancer survival for patients living and receiving care in LondonThis study highlights the need to better coordinate primary and secondary care sectors in some areas of London to improve timely access to specialised clinicians and diagnostic tests.
Social Media Disclaimer
Any follows, reposts, or replies to our social media accounts should not be considered as an endorsement by ICON of any specific messages, opinions or organisations.